CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that, in […]

SANTA CLARA, Calif.–(BUSINESS WIRE)–#IPO–SiTime Corporation, a market leader in MEMS timing, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange […]

Social Capital Hedosophia Holdings Corp. to Merge with Virgin Galactic Pending Shareholder Vote By John Jannarone and Oliver Estreich One critical factor in the 1960s Space Race was a need […]

NEW YORK–(BUSINESS WIRE)–Union Acquisition Corp. II (NASDAQ: LATNU) (the “Company”) announced today that it closed its initial public offering of 20,000,000 units, including 2,500,000 units subject to the underwriters’ over-allotment […]

Over the past few years, we’ve seen a number of interesting and much-anticipated IPOs—perhaps even more so in 2019. IPO Edge, with the help of Sentieo, has provided analysis that […]

NEW YORK–(BUSINESS WIRE)–Union Acquisition Corp. II (NASD: LATNU) (the “Company”) announced today that it priced its initial public offering of 17,500,000 units at $10.00 per unit. The units will commence […]

BUFORD, Ga.–(BUSINESS WIRE)–OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater”) announced today that it has launched an initial public offering of 3,157,895 shares of its Class A common stock at an anticipated […]

The delayed IPO of food-delivery startup Postmates is a clear result of catastrophic trading in several tech unicorns that have gone public in 2019 such as Uber Technologies, Inc. and […]

  Looks Toward Growth in Rural Chinese Networks as Key for Q3 By IPO Edge Editorial Staff Chinese e-commerce giant JD.com, Inc. (NASDAQ:JD) reported second quarter results on Tuesday, August 13, smashing its […]

PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced that it […]